This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giguère, J.-F.
Right arrow Articles by Tremblay, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giguère, J.-F.
Right arrow Articles by Tremblay, M. J.

 Previous Article  |  Next Article 

Journal of Virology, November 2004, p. 12062-12065, Vol. 78, No. 21
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.21.12062-12065.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Statin Compounds Reduce Human Immunodeficiency Virus Type 1 Replication by Preventing the Interaction between Virion-Associated Host Intercellular Adhesion Molecule 1 and Its Natural Cell Surface Ligand LFA-1

Jean-François Giguère and Michel J. Tremblay*

Research Center in Infectious Diseases, CHUL Research Center, and Faculty of Medicine, Laval University, Quebec, Canada

Received 27 April 2004/ Accepted 16 June 2004

A variety of host factors, including membrane proteins acquired by human immunodeficiency virus type 1 (HIV-1), play a dominant role in HIV-1 adsorption onto host cells. Examples include the integrin intercellular adhesion molecule 1 (ICAM-1), which, once acquired by HIV-1, promotes virus infectivity via ligation to LFA-1. We tested the ability of statins to diminish HIV-1 replication, based on the idea that these compounds have been shown to block ICAM-1-LFA-1 interactions. Our data indicate that statins diminish HIV-1 attachment to target cells by suppressing ICAM-1-LFA-1 interactions. The capacity of statins to limit the initial steps in virus replication could represent an interesting approach for the treatment of HIV-1 infection.

* Corresponding author. Mailing address: Laboratory of Human Immuno-Retrovirology, Research Center in Infectious Diseases, RC709, CHUL Research Center, 2705 Laurier Blvd., Quebec (QC), Canada G1V 4G2. Phone: (418) 654-2705. Fax: (418) 654-2212. E-mail: michel.j.tremblay{at}crchul.ulaval.ca.

Journal of Virology, November 2004, p. 12062-12065, Vol. 78, No. 21
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.21.12062-12065.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Tardif, M. R., Gilbert, C., Thibault, S., Fortin, J.-F., Tremblay, M. J. (2009). LFA-1 Antagonists as Agents Limiting Human Immunodeficiency Virus Type 1 Infection and Transmission and Potentiating the Effect of the Fusion Inhibitor T-20. Antimicrob. Agents Chemother. 53: 4656-4666 [Abstract] [Full Text]  
  • Mira, E., Leon, B., Barber, D. F., Jimenez-Baranda, S., Goya, I., Almonacid, L., Marquez, G., Zaballos, A., Martinez-A., C., Stein, J. V., Ardavin, C., Manes, S. (2008). Statins Induce Regulatory T Cell Recruitment via a CCL1 Dependent Pathway. J. Immunol. 181: 3524-3534 [Abstract] [Full Text]  
  • Negredo, E., Puigdomenech, I., Marfil, S., Puig, J., Perez-Alvarez, N., Ruiz, L., Rey-Joly, C., Clotet, B., Blanco, J. (2008). Association between HIV replication and cholesterol in peripheral blood mononuclear cells in HIV-infected patients interrupting HAART. J Antimicrob Chemother 61: 400-404 [Abstract] [Full Text]  
  • Gupta, R., Plantinga, L. C., Fink, N. E., Melamed, M. L., Coresh, J., Fox, C. S., Levin, N. W., Powe, N. R. (2007). Statin Use and Hospitalization for Sepsis in Patients With Chronic Kidney Disease. JAMA 297: 1455-1464 [Abstract] [Full Text]  
  • Acheampong, E., Parveen, Z., Mengistu, A., Ngoubilly, N., Wigdahl, B., Lossinsky, A. S., Pomerantz, R. J., Mukhtar, M. (2007). Cholesterol-Depleting Statin Drugs Protect Postmitotically Differentiated Human Neurons against Ethanol- and Human Immunodeficiency Virus Type 1-Induced Oxidative Stress In Vitro. J. Virol. 81: 1492-1501 [Abstract] [Full Text]  
  • Bukrinsky, M., Sviridov, D. (2006). Human immunodeficiency virus infection and macrophage cholesterol metabolism.. J. Leukoc. Biol. 80: 1044-1051 [Abstract] [Full Text]  
  • Hothersall, E, McSharry, C, Thomson, N C (2006). Potential therapeutic role for statins in respiratory disease.. Thorax 61: 729-734 [Abstract] [Full Text]  
  • Kolegraff, K., Bostik, P., Ansari, A. A. (2006). Characterization and role of lentivirus-associated host proteins.. Exp. Biol. Med. 231: 252-263 [Abstract] [Full Text]  
  • Tardif, M. R., Tremblay, M. J. (2005). LFA-1 Is a Key Determinant for Preferential Infection of Memory CD4+ T Cells by Human Immunodeficiency Virus Type 1. J. Virol. 79: 13714-13724 [Abstract] [Full Text]  
  • Barnard, A. L., Igakura, T., Tanaka, Y., Taylor, G. P., Bangham, C. R.M. (2005). Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes. Blood 106: 988-995 [Abstract] [Full Text]  
  • Tardif, M. R., Tremblay, M. J. (2005). Regulation of LFA-1 Activity through Cytoskeleton Remodeling and Signaling Components Modulates the Efficiency of HIV Type-1 Entry in Activated CD4+ T Lymphocytes. J. Immunol. 175: 926-935 [Abstract] [Full Text]  
  • Nguyen, D. H., Taub, D. D. (2004). Targeting Lipids to Prevent HIV Infection. Mol. Interv. 4: 318-320 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»